The place of thalidomide in the treatment of inflammatory disease

Abstract

Get full access to this article

View all access options for this article.

References

Crawford CL Thalidomide neuropathy. Nature Med 1996; 2(2): 132.

Gardner-Medwin JM , Powell RJ Thalidomide - the way forward. Postgrad Med J 1994; 70: 860-862.

Sheskin J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Therap 1965; 6: 303-306.

Grosshans E. , Illy G. Thalidomide therapy for inflammatory dermatoses . Int J Dermatol 1984; 23: 598-602.

Heney D. , Norfolk DR , Wheeldon J. , Bailey CC , Lewis IJ , Barnard SL Thalidomide treatment for chronic graft versus host disease. Br J Haematol 1991; 78: 23-27.

Choa N. , Nadermanee A. , O'Donnell MR , et al. Thalidomide for salvage therapy in chronic graft vs host disease . Blood 1995; 86(6): 3604-3609.

Soylan T. , Saltik I. Thalidomide in the treatment of Bechet's syndrome. Arch Dermatol 1982; 118: 536.

Gardner-Medwin Jmm , Smith NJ , Powell RJ Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Bechet's disease: use of neurophysiological studies to detect thalidomide neuropathy . Ann Rheum Dis 1994; 53: 828-832.

Youle M. , Clabour J. , Farthing C. , et al. Treatment of resistant apthous ulceration with thalidomide in patients positive for HIV antibody. Br Med J 1989; 298: 432.

10.

Ryan J. , Coleman J. , Pedersen J. , Benson E. Thalidomide to treat oesophageal ulcers in AIDS. N Engl J Med 1992; 327: 208-209.

11.

Rubio JB , Gonzalez FF Lupus eritematoso discoide y Talidomida. Dermatol Rev Mex 1975; 19: 131-139.

12.

Knop J. , Bonsmann G. , Happle R. , Ludolph A. , Matz DR , Mifsud EJ , Macher E. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus . Br J Dermatol 1983; 108: 461-466.

13.

Hasper MF Chronic cutaneous lupus erythematosus. Thalidomide treatment of eleven patients . Arch Dermatol 1983; 119: 812-815.

14.

Atra E. , Sato EI Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide . Clin Exp Rheumatol 1993 ; 11: 487-493.

15.

Naafs B. , Bakkers Ejm , Flinterman J. , Faber WR Thalidomide treatment of subacute cutaneous lupus erythematosus. Br J Dermatol 1982 ; 107: 83-86.

16.

Civatte J. Lupus erythemateux a type d'erytheme anulaire centrifuge; traitment par la thalidomide. J Dermatol Paris 1980; 9.

17.

Bessis D. , Guillot B. , Monpoint S. Dandurand M , Guilhou JJ Thalidomide for systemic lupus erythematosus. Lancet 1992; 339: 549-550.

18.

Stevens RJ , Andujar C. , Edwards CJ , Ames Prj , Barwick AR , Khamashta MA , Hughes Grv. Thalidomide in the treatment of cutaneous manifestations of lupus eythematosus: experience in sixteen consecutive patients. Br J Rheumatol (in press).

19.

Sampaio EP , Sarno EN , Galilly R. , Cohn ZA , Kaplan G. Thalidomide selectively inhibits tumour necrosis factor a production by stimulated human monocytes. J Exp Med 1991 ; 173: 699-703.

20.

Sampaio EP , Kaplan G. , Miranda A. , Nery Jac , Miguel CP , Viana SM , Sarno EN The influence of thalidomide on the clinical and immunologic manifestation of Erythema Nodosum Leprosum. J Infect Dis 1993; 168: 408-414.

21.

Shannon EJ , Miranda RO , Morales MJ , et al. Inhibition of de novo synthesis of IgM by thalidomide as a relevant mechanism of action in leprosy. Scand J Immunol 1981; 13: 553.

22.

Gad SM , Shannon EJ , Krotoski WA , Hasting RC Thalidomide induces imbalances in the T-lymphocyte sub-populations in the circulating blood of healthy males. Lepr Rev 1985; 56: 35-39.

23.

McHugh SM , Rifkin IR , Deighton J. , Wilson AB , Lachmann PJ , Lockwood CM , Ewan PW The immunosuppressive drug thalidomide induces T helper cell 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen and antigen stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99(2): 160-167.

24.

Faure M. , Thivolet J. , Gaucherand M. Inhibition of polymorphonuclear leukocyte chemotaxis by thalidomide . Arch Dermatol Res 1980; 263: 275-280.

25.

Barnhill RL , Doll NJ , Milikan LE , Hasting RC Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocyte and monocyte . J Am Acad Dermatol 1984; 11: 814-819.

26.

D'Amato RJ , Loughnan MS , Flynn Evelyn, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-4085.

27.

Helm FC , Frankus E. , Friderichs E. et al. Comparative teratological investigation compounds structurally and pharmacologically related to thalidomide. Arzneimittelforsch 1981; 31: 941.

28.

Sheshkin J. Study with nine thalidomide derivatives in the lepra reaction. Int J Dermatol 1978; 17: 82.

29.

Neubert R. , Hinz N. , Thiel R. , Neubert D. Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of teratogenic action of thalidomide. Life Sciences 1995; 58(4): 295-316.

30.

Fullerton PM , Kremer M. Neuropathy after intake of thalidomide (Distival) . Br Med J 1961; 2: 853-858.

31.

Fullerton PM , O'Sullivan, DJ

Thalidomide neuropathy: a clinical, electrophysiological and histological follow-up study. J Neurol Neurosuerg

Psychiatry 1968; 31: 543-551.

32.

Ochonisky S. , Verroust J. , Bastiju-Garin S. , Gheradi R. , Revuz J. Thalidomide neuropathy: incidence and electrophysiologic findings in 42 patients. Arch Dermatol 1994 ; 130: 66-69.

33.

Powell RJ , Gardner-Medwin Jmm. Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J 1994; 70: 901-904.